Director, Cardiometabolic Health Product Marketing

USA (Remote)

$186K/yr – $243K/yrDirector/Executive10+ years expFull time

Posted 4 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the cardiometabolic go-to-market and act as the connective tissue between product, clinical and commercial teams to launch new offerings and sharpen competitive positioning.

  • GTM ownership: shape portfolio strategy, packaging, pricing, and launches for the cardiometabolic suite.
  • Team and cross-functional leadership: steer 2–3 PMMs and align product, clinical, and commercial partners around customer insights and market feedback.

Job Description

  • Drive strategy across our full cardiometabolic suite - including diabetes, hypertension, prediabetes, weight management, cholesterol and GLP-1 programs - with an emphasis on new products coming to market.
  • Lead a team of 2-3 product marketers and partner across product, clinical and commercial teams to synthesize market feedback, understand our business buyers and their buying process and shape the go-to-market process.
  • Be a strategic thinker, a skilled storyteller and experienced cross-functional operator.
  • Own positioning, GTM strategy and sales enablement across all stakeholder audiences serving as the subject matter expert who helps widen the gap between Omada and our competitors and ensures the successful launch of new offerings.
  • Partner with cardiometabolic product and commercial leadership on portfolio strategy and GTM planning, with priority on new product launches.
  • Be the voice of the customer for R&D and commercial teams, using insights gathered from research, data, marketing intelligence, and customer and member needs.
  • Help shape product and go-to-market road maps based on market gaps, competitive intelligence, and customer and member needs across the cardiometabolic portfolio.
  • Clearly define and articulate our competitive position for our cardiometabolic suite and each new product entering the market.
  • Lead packaging and pricing for our cardiometabolic products - including go-to-market packaging for new offerings to ensure alignment with the market.
  • Own the positioning and messaging across the cardiometabolic suite, ensuring an integrated portfolio narrative and clear differentiation for new products.
Omada Health logo

Omada Health

3.9 Glassdoor

For 15 years, Omada Health has been in the corner of millions of Americans managing chronic conditions. We help our members between doctor visits, providing virtual care that adapts to real life.We partner with employers, health plans, pharmacy benefit managers, and government agencies to support their populations across common chronic conditions — from prediabetes, diabetes, and hypertension to muscle and joint pain— all through the convenience of an app. Our programs also adapt to provide specialized care for GLP-1 journeys.At Omada, care isn’t built for perfection. It’s built for real people. Our clinically-validated programs combine human connection with modern technology, pairing members with real coaches and care teams.Omada’s impact is proven: our outcomes are published in 30 peer-reviewed studies, showing lasting behavior change, reduced healthcare costs, and ROI for our partners.Our success starts with our people. Omada’s strong, inclusive culture has earned us the Great Place to Work certification, and in 2025 we became a Nasdaq-listed company — a milestone on our mission to bend the curve of chronic disease.

Founded in 2011
San Francisco, California, USA
917 employees (53 in marketing)
71% recommend to a friend
90% CEO approval

Traffic Signals

Monthly Visitors
343.4K
Monthly Google Ads Budget
$34.9K
Traffic Source Mix
Search
27.1%
Direct
67.3%
Referral
4%
Social
0.8%
Paid
0.6%

Headcount Trend

Current headcount: ~917

Marketing Team

Marketing Team Size
43 (5% of company)
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$528.5M
Last Raise
$80M
Secondary Market, 10 months ago

Funding History

  • May 2025
    Secondary Market
  • Jan 2023
    Debt Financing • $80M
  • Feb 2022
    Series E • $192M

Recent News